PL3781210T3 - Leczenie niedociśnienia w przypadku sepsy lub wstrząsu septycznego - Google Patents

Leczenie niedociśnienia w przypadku sepsy lub wstrząsu septycznego

Info

Publication number
PL3781210T3
PL3781210T3 PL19717944.3T PL19717944T PL3781210T3 PL 3781210 T3 PL3781210 T3 PL 3781210T3 PL 19717944 T PL19717944 T PL 19717944T PL 3781210 T3 PL3781210 T3 PL 3781210T3
Authority
PL
Poland
Prior art keywords
hypotension
sepsis
treatment
septic shock
septic
Prior art date
Application number
PL19717944.3T
Other languages
English (en)
Inventor
Samareh Azeredo Da Silveira Lajaunias
Frédéric LAJAUNIAS
Original Assignee
Combioxin Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62044543&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3781210(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Combioxin Sa filed Critical Combioxin Sa
Publication of PL3781210T3 publication Critical patent/PL3781210T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL19717944.3T 2018-04-20 2019-04-18 Leczenie niedociśnienia w przypadku sepsy lub wstrząsu septycznego PL3781210T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18168436 2018-04-20
PCT/EP2019/060143 WO2019202101A1 (en) 2018-04-20 2019-04-18 Treatment of sepsis and septic shock

Publications (1)

Publication Number Publication Date
PL3781210T3 true PL3781210T3 (pl) 2024-11-12

Family

ID=62044543

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19717944.3T PL3781210T3 (pl) 2018-04-20 2019-04-18 Leczenie niedociśnienia w przypadku sepsy lub wstrząsu septycznego

Country Status (18)

Country Link
US (2) US20210259967A1 (pl)
EP (2) EP4467197A3 (pl)
JP (3) JP7524072B2 (pl)
CN (2) CN111971068B (pl)
AU (1) AU2019254640B2 (pl)
CA (1) CA3097045A1 (pl)
DK (1) DK3781210T5 (pl)
ES (1) ES2987792T3 (pl)
FI (1) FI3781210T3 (pl)
HR (1) HRP20241358T1 (pl)
HU (1) HUE068607T2 (pl)
LT (1) LT3781210T (pl)
PL (1) PL3781210T3 (pl)
PT (1) PT3781210T (pl)
RS (1) RS66040B1 (pl)
SI (1) SI3781210T1 (pl)
SM (1) SMT202400412T1 (pl)
WO (1) WO2019202101A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023520393A (ja) * 2020-04-03 2023-05-17 ビバセレ バイオ インコーポレーテッド 多臓器機能不全症候群を治療又は予防するための組成物及び方法
GB202113028D0 (en) * 2021-09-13 2021-10-27 Ucl Business Ltd Sterol therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992022320A1 (en) * 1991-06-14 1992-12-23 Genentech, Inc. C1 inhibitor variants and treating inflammatory response with c1 inhibitor
US8906855B2 (en) 2007-12-22 2014-12-09 Vivacelle Bio, Inc. Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
WO2012021829A1 (en) * 2010-08-12 2012-02-16 Tetraphase Pharmaceuticals, Inc. Methods of treating bacterial infections
WO2012091706A1 (en) * 2010-12-29 2012-07-05 Halliburton Energy Services, Inc. Subsea pressure control system
US20130296223A1 (en) * 2012-03-30 2013-11-07 Sciclone Pharmaceuticals, Inc. Use of thymosin alpha for the treatment of sepsis
BR112014031278B1 (pt) 2012-06-14 2020-12-01 Universitaet Bern uso de lipossomos vazios, mistura de lipossomos vazios, bicamadas lipídicas ou monocamadas lipídicas, bem como mistura de lipossomos vazios
DK3471732T3 (da) 2016-06-16 2020-08-17 Combioxin Sa Liposomer til behandling af virusinfektioner
WO2017222912A1 (en) 2016-06-20 2017-12-28 Vivacelle Bio, Inc. Compositions and methods for reducing reperfusion injury
CN116549393A (zh) * 2017-03-02 2023-08-08 康柏辛股份有限公司 抑制生物膜形成的脂质体

Also Published As

Publication number Publication date
WO2019202101A9 (en) 2020-10-29
RS66040B1 (sr) 2024-11-29
CN111971068A (zh) 2020-11-20
EP3781210B1 (en) 2024-08-07
WO2019202101A1 (en) 2019-10-24
CN111971068B (zh) 2025-09-02
AU2019254640A1 (en) 2020-11-26
DK3781210T3 (da) 2024-08-19
CN121102236A (zh) 2025-12-12
PT3781210T (pt) 2024-10-02
EP3781210A1 (en) 2021-02-24
EP4467197A2 (en) 2024-11-27
AU2019254640B2 (en) 2024-11-28
HUE068607T2 (hu) 2025-01-28
SMT202400412T1 (it) 2024-11-15
CA3097045A1 (en) 2019-10-24
ES2987792T3 (es) 2024-11-18
JP2024099554A (ja) 2024-07-25
JP2021522205A (ja) 2021-08-30
EP4467197A3 (en) 2025-01-29
JP2025165965A (ja) 2025-11-05
US20210259967A1 (en) 2021-08-26
HRP20241358T1 (hr) 2024-12-20
JP7524072B2 (ja) 2024-07-29
DK3781210T5 (da) 2024-08-26
SI3781210T1 (sl) 2024-12-31
LT3781210T (lt) 2024-09-10
FI3781210T3 (fi) 2024-09-12
US20250000795A1 (en) 2025-01-02

Similar Documents

Publication Publication Date Title
GB201804514D0 (en) Treatment of pyroptosis
GB2589217B (en) At-the-bit mud loss treatment
ZA202003267B (en) Novel combinations of defoliants
IL276312B1 (en) Use of Alkoxypyrazoles as nitrification inhibitors
EP3701179A4 (en) LINE ORGANIZER
EP3947296A4 (en) Sewage treatment method
ZA201903795B (en) Treatment of water
PL3826983T3 (pl) Zastosowanie podstawionych 2-tiazolin jako inhibitorów nitryfikacji
LT3781210T (lt) Gydymas hipotenzijos su sepsiu arba septiniu šoku
GB201804515D0 (en) Treatment of necroptosis
HUE062859T2 (hu) Szennyvíz kezelése
HUE064273T2 (hu) Eljárások iszap vízteleníthetõségének fokozására enzimes kezeléssel
GB201914233D0 (en) Phage cyclisation assay
IT201700122785A1 (it) Sospensioni non acquose
IL274979A (en) Methods for the prevention and treatment of neurogenic seizures
EP3965707C0 (en) DEVICES TO ALLEVIATE ERECTILE DYSFUNCTION
IL274031A (en) IL-8 inhibitors for use in the treatment of certain sarcomas
IL272023A (en) Methods of treating symptoms of gastroparesis using velusetrag
SI3781172T1 (sl) Zdravljenje pljučnice
EP3454002C0 (en) MULTI-ANGLE MUD LANCE
GB201610574D0 (en) Aerated wastewater treatment
EP3908695C0 (de) Wegkörper
GB2580157B (en) Treatment of produced hydrocarbons
ZA201906542B (en) Process for the treatment of wastewater
PH32019001056S1 (en) Lunchbox